Skip to content

EVALUATION OF DRUG COUNSELING FOR PATIENTS WITH HEART DISEASE.

EVALUATION OF PHARMACEUTICAL CARE FOR PATIENTS WITH CARDIOVASCULAR DISEASES

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/08/004928
Enrollment
69
Registered
2014-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENTS ADMITTED WITH MYOCARDIAL INFARCTION AND UNSTABLE ANGINA FOR ANGIOPLASTY PROCEDURE

Interventions

Intervention1: PHARMACEUTICAL CARE: PATIENT WILL RECEIVE DIET, DRUG,DISEASE INFORMATION AND LIFESTYLE MODIFICATIONS TILL 12 MONTHS AT THE TIME POINTS,DURING DISCHARGE, AFTER 3 MONTHS, 6 MONTHS, 9 MONT

Sponsors

ANIL TM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hospitalization for at least 24 hours & discharged with prescription for medicines to Home. PATIENTS WITH MYOCARDIAL INFARCTION AND UNSTABLE ANGINA

Exclusion criteria

Exclusion criteria: PATIENTS WHO HAD ANGIOPLASTY PROCEDURE EARLIER PATIENTS WITH PSYCHIATRIC DISORDERS PREGNANT WOMEN PATIENTS WHO ARE NOT INTERESTED TO PARTICIPATE

Design outcomes

Primary

MeasureTime frame
ECONOMICAL OUTCOME - COST UTILITY ANALYSIS CLINICAL OUTCOME- MEDICATION ADHERENCE, LIPID PROFILE, B.P, FASTING BLOOD SUGAR AND GLYCOLATED HAEMOGLOBIN LEVELS HUMANISTIC OUTCOMES- QUALITY OF LIFETimepoint: 3 MONTHS, 6 MONTHS, 9 MONTHS AND 12 MONTHS

Secondary

MeasureTime frame
QUALITY ADJUSTED LIFE YEARS Timepoint: 12 MONTHS

Countries

India

Contacts

Public ContactANIL TM

MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES,

anantha1232000@gmail.com9900407416

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026